We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Sirolimus Treatment for Refractory PRCA

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03364764
Recruitment Status : Completed
First Posted : December 7, 2017
Last Update Posted : July 6, 2021
Information provided by (Responsible Party):
Bing Han, Peking Union Medical College Hospital